.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Children living with heart disease often face significant emotional challenges and psychological stress. Therefore, the implementation of efficient pediatric anxiety screening tools has become a priority for specialized clinics. Traditional assessments, such as the Screen for Child Anxiety Related Emotional Disorders (SCARED), are frequently too long for a busy outpatient environment. Consequently, a recent study sought to validate a briefer alternative to improve the screening process for these vulnerable patients.
Anxiety disorders are prevalent among children with congenital, arrhythmic, and acquired heart diseases. However, many clinicians struggle to fit mental health evaluations into routine cardiac follow-ups. This study specifically evaluated the concurrent validity of the Pediatric-Reported Outcomes Measurement Information System Pediatric Anxiety (PROMIS-Anx) tool. By comparing it to the SCARED legacy measure in children aged 7.5 and older, researchers aimed to find a more practical solution for daily practice.
The results of the validation study suggest that PROMIS-Anx is highly effective and reliable. Furthermore, the tool significantly reduces the time burden on both patients and healthcare providers. Because the short form focuses on core symptoms like fear and worry, it provides a clear picture of a child's mental state quickly. Ultimately, adopting such pediatric anxiety screening tools ensures that emotional distress does not go unnoticed during cardiac care.
Clinicians in India and globally can benefit from integrating these brief assessments into their workflow. Early identification of anxiety allows for timely referrals to psychiatric specialists or behavioral therapists. Additionally, families often express high receptiveness to these screenings, as they appreciate the holistic approach to their child's health. This validation confirms that diagnostic accuracy remains high even when using shorter instruments.
The PROMIS-Anx is a much briefer instrument designed for rapid administration in busy clinics. While the SCARED tool is a comprehensive legacy measure, PROMIS-Anx provides a validated, time-saving alternative without sacrificing diagnostic reliability.
Children with heart disease have a higher susceptibility to anxiety disorders due to chronic illness and medical procedures. Routine screening helps identify these issues early, allowing for integrated care that addresses both physical and emotional health.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ahmad S et al. Validation of a Briefer Anxiety Screening Tool for Use in Pediatric Cardiology Clinics. JACC Adv. 2026 Jun 04. doi: undefined. PMID: 42241734.
Parkhurst JT et al. Comparative analysis of pediatric anxiety measures in clinical sample: evaluation of the PROMIS pediatric anxiety short forms. Qual Life Res. 2023 Jun;32(6):1621-1630. doi: 10.1007/s11136-022-03333-6.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent study validates the PROMIS-Anx tool as a time-efficient alternative to the SCARED screening tool for pediatric heart disease patients....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
